Curis Inc (CRIS) Stock Price, Quote & News

Company Profile

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed/refractory primary central nervous system lymphoma. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes fo...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 503 6500

Website: www.curis.com

Address:

Building C, Suite 500 128 Spring Street, Lexington, United States

SadyK189 Jul. 3 at 7:43 PM

A look at recent runners and whats next for them: $SDOT $LHAI $BIYA $FCEL $CRIS SDOT: Initially alerted at 6.43. It made a massive run to 105. You will find lot of posts in my profile regarding next key levels and support zone on my profile. Currently at 51. Still looking good on daily chart with key support at 37 - 41. It can test 68 - 73 zone again. LHAI: Consolidating on 4hours chart with key support zone at 1.2 - 1.35. Currently at 1.71. Next key level to test 2.35 - 2.65. BIYA: Still looking good on 4hours chart. Key support zone at 0.38 - 0.41. Next key level to test 0.73 - 0.78. Currently at 0.56 FCEL: Initially alerted at 14.75. It went till 37.87 afterwards. Currently at 28. Still looking good on daily chart with key support zone at 19 - 21.5. Next key level to test 34 - 37. CRIS: With 1 / 20 Split on Monday it can provide good scalping opportunities of 15 - 20%. Entry on confirmation though.

1 · Reply

Breton2018 Jul. 3 at 10:05 AM

$CRIS Halted over weekend

0 · Reply

TwongStocks Jul. 2 at 8:39 PM

Ten (!!) NASDAQ stocks with reverse splits on Monday. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am ET Monday morning. I'll have to split this summary into two parts. Part 1 of 2: $ABTC 1 for 15. Will reduce outstanding Class A shares from approx 360.07m to approx 24m. $CRIS 1 for 20. Will reduce outstanding shares from approx 38.98m to approx 1.95m. $HKIT 1 for 25. Will reduce outstanding Class A shares from approx 20m to approx 800k. $INLF 1 for 200. Will reduce outstanding Class A shares from approx 209.38m to approx 1.05m. $JZ 1 for 30. Will reduce outstanding ADS from approx 32.09m to approx 1.07m.

0 · Reply

Jumpmanz Jul. 2 at 2:36 AM

$CRIS

0 · Reply

LodiDodiWeLikesToParty Jul. 1 at 9:17 PM

$CRIS Soooo, my once 3881 shares that you split to 199 shares, will now be split to only 10 shares. POS company. How do you sleep at night, stealing people's money?

1 · Reply

MarketsParadise Jul. 1 at 8:43 PM

Small caps heating up, We are seeing some big runners lately. Take a look at ticker DRCT 💎 I believe this is the next monster runner waiting to be found: DRCT 💎 • 600K share float--Nano float! • AI-powered digital advertising & marketing drive • Extremely thin chart • Any sustained buying pressure we look for the 5$+. $YHC $SKYQ $TNMG $CRIS ..1155

1 · Reply

Unburdened Jul. 1 at 8:35 PM

$CRIS Dog Sh$& company with Dog Sh$& management. Love how they suckered in the last group of investors.

0 · Reply

Scotsman85 Jul. 1 at 6:33 PM

$CRIS rocket

0 · Reply

TwongStocks Jul. 1 at 6:17 PM

$CRIS Equity Corporate Actions Alert #2026 - 454 Information Regarding the Reverse Stock Split and CUSIP Number Change for Curis, Inc. (CRIS) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-454 Curis, Inc. (CRIS) will effect a one-for-twenty (1-20) reverse split of its common stock. The reverse stock split will become effective on Monday, July 6, 2026. In conjunction with the reverse split, the CUSIP number will change to 231269408

0 · Reply

Zed799 Jul. 1 at 3:52 PM

$CRIS

1 · Reply

Curis trading halted, news pending

2026-06-26T13:50:10.000Z - 8 days ago

Curis announces eleven active clinical sites in TakeAim CLL study

Jun 26, 2026, 9:42 AM EDT - 8 days ago

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split

Jun 25, 2026, 11:00 AM EDT - 9 days ago

Curis Transcript: EGM 2026

Jun 5, 2026, 8:00 AM EDT - 4 weeks ago

Curis Proxy statement: Proxy filing

Jun 5, 2026, 7:00 AM EDT - 4 weeks ago

Curis Slides: Corporate presentation

May 22, 2026, 8:00 AM EDT - 6 weeks ago

Curis Proxy statement: Proxy filing

May 19, 2026, 11:00 AM EDT - 6 weeks ago

Curis Transcript: AGM 2026

2026-05-12T22:10:48.000Z - 7 weeks ago

Curis reports Q1 EPS ($1.25), consensus (29c)

2026-05-12T22:07:01.000Z - 7 weeks ago

Curis sees cash and proceeds enough for operations into second half of FY27

May 12, 2026, 4:30 PM EDT - 7 weeks ago

Curis Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 7 weeks ago

Curis Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 7 weeks ago

Curis Quarterly report: Q1 2026

May 12, 2026, 4:00 PM EDT - 7 weeks ago

Curis Provides First Quarter 2026 Business Update

May 5, 2026, 5:11 PM EDT - 2 months ago

Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026

Apr 21, 2026, 8:00 AM EDT - 2 months ago

Curis Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 3 months ago

Curis Proxy statement: Proxy filing

Mar 30, 2026, 7:00 AM EDT - 3 months ago

Curis Slides: Corporate presentation

Mar 19, 2026, 4:30 PM EDT - 3 months ago

Curis Earnings Call Transcript: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 3 months ago

Curis Annual report: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 3 months ago

Curis Earnings release: Q4 2025

Mar 19, 2026, 4:00 PM EDT - 3 months ago

Curis Provides Fourth Quarter 2025 Business Update

Mar 17, 2026, 11:00 AM EDT - 3 months ago

Curis Transcript: EGM 2026

Mar 12, 2026, 4:27 PM EDT - 4 months ago

Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026

Feb 19, 2026, 7:00 AM EST - 4 months ago

Curis Proxy statement: Proxy Filing

Feb 13, 2026, 7:00 AM EST - 5 months ago

Curis Registration statement: Registration Filing

Feb 9, 2026, 7:00 AM EST - 5 months ago

Curis Proxy statement: Proxy Filing

Jan 9, 2026, 8:00 AM EST - 6 months ago

Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

Jan 7, 2026, 8:45 AM EST - 6 months ago

Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

Dec 9, 2025, 8:00 AM EST - 7 months ago

Curis Provides Updated Data from its Frontline AML Triplet Study

Nov 14, 2025, 9:26 AM EST - 8 months ago

Curis to Present at Upcoming 30th Annual SNO Meeting

Nov 6, 2025, 4:30 PM EST - 8 months ago

Curis Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Curis Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Curis Earnings release: Q3 2025

Nov 6, 2025, 4:00 PM EST - 8 months ago

Curis Provides Third Quarter 2025 Business Update

Oct 30, 2025, 4:00 PM EDT - 8 months ago

Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025

Oct 3, 2025, 4:00 PM EDT - 9 months ago

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sep 10, 2025, 10:00 AM EDT - 10 months ago

Curis Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 5, 2025, 9:45 AM EDT - 10 months ago

Curis Transcript: Cantor Global Healthcare Conference 2025

Sep 2, 2025, 10:43 AM EDT - 10 months ago

Curis to Present at Upcoming Healthcare Conferences in September

Aug 11, 2025, 8:00 AM EDT - 11 months ago

Curis Registration statement: Registration Filing

Aug 5, 2025, 8:30 AM EDT - 11 months ago

Curis Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:30 AM EDT - 11 months ago

Curis Quarterly report: Q2 2025

Aug 5, 2025, 8:30 AM EDT - 11 months ago

Curis Earnings release: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 11 months ago

Curis Provides Second Quarter 2025 Business Update

Jul 29, 2025, 8:30 AM EDT - 1 year ago

Curis to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2025

Jul 2, 2025, 8:32 AM EDT - 1 year ago

Curis Announces $7.0 Million Registered Direct and Concurrent Private Placement

May 7, 2025, 8:00 AM EDT - 1 year ago

Curis Registration statement: Registration Filing

May 6, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings Call Transcript: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Curis Quarterly report: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings release: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Curis Provides First Quarter 2025 Business Update

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025

Apr 10, 2025, 8:00 AM EDT - 1 year ago

Curis Proxy statement: Proxy Filing

Apr 10, 2025, 8:00 AM EDT - 1 year ago

Curis Proxy statement: Proxy Filing

Apr 9, 2025, 4:30 PM EDT - 1 year ago

Curis Transcript: Jones Healthcare and Technology Innovation Conference 2025

Apr 2, 2025, 4:05 PM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conference in April

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings Call Transcript: Q4 2024

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Curis Annual report: Q4 2024

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings release: Q4 2024

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Curis Provides Fourth Quarter 2024 Business Update

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Curis Proxy statement: Proxy Filing

Mar 28, 2025, 4:07 PM EDT - 1 year ago

Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025

Dec 23, 2024, 7:00 AM EST - 1 year ago

Curis Registration statement: Registration Filing

Dec 10, 2024, 8:00 AM EST - 1 year ago

Curis Announces Additional Data from TakeAim Leukemia Study

Nov 14, 2024, 8:30 AM EST - 1 year ago

Curis Earnings Call Transcript: Q3 2024

Nov 14, 2024, 8:30 AM EST - 1 year ago

Curis Quarterly report: Q3 2024

Nov 14, 2024, 8:30 AM EST - 1 year ago

Curis Earnings release: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

Curis Provides Third Quarter 2024 Business Update

Nov 7, 2024, 8:00 AM EST - 1 year ago

Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024

Oct 29, 2024, 6:04 AM EDT - 1 year ago

Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement

Sep 23, 2024, 8:30 AM EDT - 1 year ago

Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer

Sep 17, 2024, 3:05 PM EDT - 1 year ago

Curis Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 17, 2024, 7:30 AM EDT - 1 year ago

Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 11, 2024, 1:00 PM EDT - 1 year ago

Curis Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Curis Earnings Call Transcript: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Curis Quarterly report: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Curis Earnings release: Q2 2024

Aug 1, 2024, 8:00 AM EDT - 2 years ago

Curis Provides Second Quarter 2024 Financial and Operating Update

Jul 25, 2024, 8:00 AM EDT - 2 years ago

Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

Jul 10, 2024, 7:30 AM EDT - 2 years ago

Curis to Present at Upcoming Healthcare Conference in July

May 14, 2024, 4:30 PM EDT - 2 years ago

Curis Transcript: Status Update

May 10, 2024, 8:00 AM EDT - 2 years ago

Curis to Present Updated Data from the TakeAim Leukemia Study

May 7, 2024, 8:30 AM EDT - 2 years ago

Curis Earnings Call Transcript: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

Curis Quarterly report: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

Curis Earnings release: Q1 2024

May 7, 2024, 8:00 AM EDT - 2 years ago

Curis Provides First Quarter 2024 Business Update

Apr 30, 2024, 8:00 AM EDT - 2 years ago

Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024

Apr 10, 2024, 8:00 AM EDT - 2 years ago

Curis Proxy statement: Proxy Filing

Apr 10, 2024, 8:00 AM EDT - 2 years ago

Curis Proxy statement: Proxy Filing

Apr 8, 2024, 12:45 PM EDT - 2 years ago

Curis Transcript: 23rd Annual Needham Virtual Healthcare Conference

Apr 5, 2024, 7:00 AM EDT - 2 years ago

Curis Slides: Corporate Presentation

Apr 4, 2024, 7:30 AM EDT - 2 years ago

Curis to Present at Upcoming Healthcare Conferences in April

Mar 29, 2024, 8:00 AM EDT - 2 years ago

Curis Proxy statement: Proxy Filing

Feb 8, 2024, 8:30 AM EST - 2 years ago

Curis Earnings Call Transcript: Q4 2023

Feb 8, 2024, 8:30 AM EST - 2 years ago

Curis Annual report: Q4 2023

Feb 8, 2024, 8:30 AM EST - 2 years ago

Curis Earnings release: Q4 2023

Feb 8, 2024, 8:00 AM EST - 2 years ago

Curis Provides Fourth Quarter 2023 Business Update

Feb 8, 2024, 7:00 AM EST - 2 years ago

Curis Registration statement: Registration Filing

Feb 1, 2024, 8:00 AM EST - 2 years ago

Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024

Dec 12, 2023, 8:00 AM EST - 2 years ago

Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study

Dec 11, 2023, 8:00 AM EST - 2 years ago

Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference

Dec 6, 2023, 8:00 AM EST - 2 years ago

Curis Announces Three Presentations at ASH

Dec 5, 2023, 8:00 AM EST - 2 years ago

Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma

Nov 17, 2023, 9:04 AM EST - 2 years ago

Curis's stock rises as analysts see ‘the next Pharmacyclics'

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Curis Earnings Call Transcript: Q3 2023

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Curis Quarterly report: Q3 2023

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Curis Earnings release: Q3 2023

Nov 2, 2023, 8:00 AM EDT - 2 years ago

Curis Provides Third Quarter 2023 Business Update

Oct 26, 2023, 8:30 AM EDT - 2 years ago

Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023

Sep 12, 2023, 8:00 AM EDT - 3 years ago

Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer

Aug 18, 2023, 8:00 AM EDT - 3 years ago

Curis Proxy statement: Proxy Filing

Aug 4, 2023, 8:00 AM EDT - 3 years ago

Curis Proxy statement: Proxy Filing

Aug 3, 2023, 4:30 PM EDT - 3 years ago

Curis Earnings Call Transcript: Q2 2023

Aug 3, 2023, 4:30 PM EDT - 3 years ago

Curis Quarterly report: Q2 2023

Aug 3, 2023, 4:30 PM EDT - 3 years ago

Curis Earnings release: Q2 2023

Aug 3, 2023, 4:01 PM EDT - 3 years ago

Curis Provides Second Quarter 2023 Business Update

Jul 27, 2023, 6:25 PM EDT - 3 years ago

Curis to Release Second Quarter 2023 Financial Results and Hold Conference Call on August 3, 2023

Jul 6, 2023, 8:01 AM EDT - 3 years ago

FDA Removes Partial Clinical Hold on TakeAim Leukemia Study RP2D Established at 300 mg BID

Jul 6, 2023, 8:00 AM EDT - 3 years ago

Curis Announces $15.1 Million Registered Direct Offering

May 4, 2023, 4:30 PM EDT - 3 years ago

Curis Earnings Call Transcript: Q1 2023

May 4, 2023, 4:30 PM EDT - 3 years ago

Curis Quarterly report: Q1 2023

May 4, 2023, 4:30 PM EDT - 3 years ago

Curis Earnings release: Q1 2023

May 4, 2023, 4:01 PM EDT - 3 years ago

Curis Provides First Quarter 2023 Business Update

SadyK189 Jul. 3 at 7:43 PM

1 · Reply

Breton2018 Jul. 3 at 10:05 AM

$CRIS Halted over weekend

0 · Reply

TwongStocks Jul. 2 at 8:39 PM

0 · Reply

Jumpmanz Jul. 2 at 2:36 AM

$CRIS

0 · Reply

LodiDodiWeLikesToParty Jul. 1 at 9:17 PM

$CRIS Soooo, my once 3881 shares that you split to 199 shares, will now be split to only 10 shares. POS company. How do you sleep at night, stealing people's money?

1 · Reply

MarketsParadise Jul. 1 at 8:43 PM

1 · Reply

Unburdened Jul. 1 at 8:35 PM

$CRIS Dog Sh$& company with Dog Sh$& management. Love how they suckered in the last group of investors.

0 · Reply

Scotsman85 Jul. 1 at 6:33 PM

$CRIS rocket

0 · Reply

TwongStocks Jul. 1 at 6:17 PM

0 · Reply

Zed799 Jul. 1 at 3:52 PM

$CRIS

1 · Reply

winnercircle123 Jul. 1 at 3:07 PM

$CRIS scammers

0 · Reply

hardrock2112 Jul. 1 at 2:20 PM

$CRIS waking up

0 · Reply

Scotsman85 Jul. 1 at 1:24 PM

$CRIS big spike up as people will be loading up before the split

0 · Reply

focafoca99 Jul. 1 at 12:16 PM

$CRIS details a 1-for-20 reverse stock split approved by its board.

1 · Reply

BallWasher69 Jul. 1 at 12:13 PM

$CRIS Board approved a 1-for-20 reverse stock split of Curis, Inc. common stock. * Shareholders had previously authorized the Board to implement a reverse split anywhere between 1-for-5 and 1-for-25. * On June 25, 2026, immediately after receiving shareholder approval, the Board chose the 1-for-20 ratio.

0 · Reply

GoldenGoy Jul. 1 at 12:04 PM

$CRIS chart looks like volitility, but its a very tight bounce

0 · Reply

topstockalerts Jun. 30 at 8:42 PM

$CRIS a lot to like about this action

0 · Reply

GoldenGoy Jun. 30 at 8:40 PM

$CRIS gonna wake up tomorrow to $12 right?

0 · Reply

GoldenGoy Jun. 30 at 8:37 PM

$CRIS seems like a good bet...

0 · Reply

SadyK189 Jun. 30 at 8:02 PM

Here is my Amazing daily "Stocktwits" report: $SDOT $FCEL $CRIS $SKYQ $PYXS SDOT My post last night "Initially alerted at 19.58. Looking good on daily chart. Key support zone at 25 - 27.40. Next key level to test 42.70 - 44.30." It made a nice move to 52.95 FCEL My post last night "Initially alerted at 11.80. Still trending strong on weekly and daily chart. Key support zone at 21 - 22.70. Next key level to test 34.45 - 34.85." It hit our desired zone, went till 37.87 CRIS My post last night "Initially alerted at 0.3 last night. Still looking good on 4hours chart. Key support zone at 0.32 - 0.36. Next key level to test 0.57 - 0.61" It went till 0.5668 SKYQ My post last night "Initially alerted at 2.28. Still looking good on 4hours chart. Key support zone at 2.55 - 2.80. Next key level to test 4.15 - 4.40." It hit our desired zone, went till 4.30 PYXS My post was "Looking good on daily chart with key support zone at 2.05 - 2.25. Next key level to test 3.35 - 3.60." It went till 3.72

1 · Reply

Slaughtertrade Jun. 30 at 7:25 PM

$CRIS is this done or what?

0 · Reply

aigoat777 Jun. 30 at 7:11 PM

$YOUL $CRIS breaking out..

0 · Reply

Market Cap	13.51M
Revenue (ttm)	9.44M
Net Income (ttm)	-7.58M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-80.30%
Debt to Equity Ratio	0.00

Volume	2,373,400
Avg Vol	3,788,222
Day's Range	N/A - N/A
Shares Out	38.98M
Stochastic %K	43%
Beta	3.08
Analysts	Sell
Price Target	$11.00